MMP2 and ovarian carcinoma: An intensification in p38 mitogen-activated protein kinase (MAPK) activity and a dose-dependent decrease in the matrix metalloproteinase-2 (MMP2) protein level were shown to limit cell the proliferation of OVCAR-3 and migration in human ovarian cancer cells (Wang et al., 2014).